A 72-year-old woman presents with a 3-year history of progressive cognitive decline and parkinsonism. Her family reports she has become increasingly confused and forgetful, with frequent episodes of visual hallucinations of people and animals. She has developed a shuffling gait and resting tremor. Examination reveals bradykinesia, rigidity, and postural instability. Cognitive testing shows impairment in attention and visuospatial function with relative preservation of language. MRI brain shows generalized cerebral atrophy without focal lobar predominance. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Lewy Body Dementia (LBD) ### Key Diagnostic Features **Key Point:** Lewy body dementia is characterized by the triad of cognitive decline, parkinsonism, and visual hallucinations, with early impairment of attention and visuospatial function. ### Clinical Presentation in This Case | Feature | Finding | Significance | |---------|---------|---------------| | **Cognitive decline** | Early memory and attention impairment | Hallmark of LBD | | **Visual hallucinations** | Detailed, recurrent (people, animals) | Highly specific for LBD | | **Parkinsonism** | Bradykinesia, rigidity, tremor, gait disorder | Motor features present | | **Visuospatial impairment** | Prominent early | Distinguishes from bvFTD | | **Language** | Relatively preserved | Typical for LBD | | **Neuroimaging** | Generalized atrophy, no focal lobar involvement | Nonspecific but consistent | ### Diagnostic Criteria for Lewy Body Dementia **High-Yield:** The McKeith criteria (2017) require cognitive decline plus two of three core features: (1) parkinsonism, (2) visual hallucinations, (3) REM sleep behavior disorder. Supportive features include sensitivity to antipsychotics, low dopamine transporter uptake on imaging, and slow-wave EEG abnormalities. ### Core Features Explained 1. **Cognitive Decline** - Early impairment of attention and executive function - Visuospatial deficits prominent - Memory relatively preserved early (unlike Alzheimer disease) - Fluctuating cognition common 2. **Visual Hallucinations** - Detailed, often non-threatening (animals, people) - Occur in 60–80% of LBD patients - Highly specific for LBD vs. other dementias - Usually preserved insight initially 3. **Parkinsonism** - Bradykinesia, rigidity, tremor, postural instability - May precede cognitive symptoms (Parkinson disease dementia) or follow (dementia with Lewy bodies) - Typically symmetric, unlike corticobasal syndrome ### Pathophysiology **Key Point:** LBD is caused by accumulation of alpha-synuclein in Lewy bodies throughout the brain, affecting dopaminergic, cholinergic, and serotonergic systems. ### Differential Diagnosis: FTD vs. LBD vs. CBS vs. PSP | Feature | bvFTD | LBD | CBS | PSP | |---------|-------|-----|-----|-----| | **Behavioral change** | Early, prominent | Late | Asymmetric motor | Apathy, vertical gaze palsy | | **Visual hallucinations** | Absent | Early, prominent | Absent | Absent | | **Parkinsonism** | Absent/mild | Prominent | Asymmetric, alien hand | Symmetric, vertical gaze | | **Memory/visuospatial** | Preserved early | Impaired early | Asymmetric cortical signs | Impaired | | **Imaging** | Frontal/temporal atrophy | Generalized atrophy | Asymmetric cortical atrophy | Midbrain atrophy | | **Language** | May be impaired | Preserved | Apraxia of speech | Dysarthria | **Clinical Pearl:** The presence of visual hallucinations in a parkinsonian patient with dementia is virtually diagnostic of LBD. Memory preservation early in the course helps distinguish LBD from Alzheimer disease. ### Management Considerations **Warning:** Antipsychotics (especially typical agents) are contraindicated in LBD — they cause severe adverse reactions and increased mortality. Use cholinesterase inhibitors (donepezil, rivastigmine) as first-line cognitive treatment. - **Cognitive:** Cholinesterase inhibitors (rivastigmine preferred) - **Parkinsonism:** Levodopa (cautiously; may worsen hallucinations) - **Hallucinations:** Quetiapine or pimavanserin (avoid haloperidol, risperidone) - **Sleep:** Melatonin or clonazepam for REM sleep behavior disorder **Mnemonic — LBD HALLMARK:** **L**ewy bodies, **B**radykinesia, **D**ementia, **H**allucinations, **A**ttention impairment, **L**oss of dopamine, **L**anguage preserved, **M**otor features, **A**lpha-synuclein, **R**EM sleep disorder, **K**eep away from antipsychotics.